Comments on: Gilead’s Seattle Crew Awaits FDA Clearance of Cystic Fibrosis Drug, Catalyst for Future Growth http://www.xconomy.com/seattle/2008/09/15/gileads-seattle-crew-awaits-fda-clearance-of-cystic-fibrosis-drug-catalyst-for-future-growth/ Business + Technology in the Exponential Economy Sat, 21 Nov 2009 22:30:41 -0600 http://wordpress.org/?v=2.8.6 hourly 1 By: mshreve http://www.xconomy.com/seattle/2008/09/15/gileads-seattle-crew-awaits-fda-clearance-of-cystic-fibrosis-drug-catalyst-for-future-growth/comment-page-1/#comment-28750 mshreve Mon, 15 Sep 2008 14:39:14 +0000 http://www.xconomy.com/?p=4841#comment-28750 We applaud Gilead for aggressively pursuing the development of ambrisentan for IPF, given that there are currentl no FDA-approved treatment options for this devastating disease that claims the lives of 40,000 Americans ach year - as many as breast cancer. IPF is a relentlessly progressive and ultimately fatal lung disorder with a median survival rate of just 3 years. In an industry where focus on rare disease research is at best a challenge, we are thrilled that Gilead is investing in new approaches to treat this disease. On behalf of our patients, their families, and the healthcare pressioanls who treat IPF, thank you. Mark Shreve Founder Coalition for Pulmonary Fibrosis (CPF) www.coalitionforpf.org We applaud Gilead for aggressively pursuing the development of ambrisentan for IPF, given that there are currentl no FDA-approved treatment options for this devastating disease that claims the lives of 40,000 Americans ach year – as many as breast cancer. IPF is a relentlessly progressive and ultimately fatal lung disorder with a median survival rate of just 3 years. In an industry where focus on rare disease research is at best a challenge, we are thrilled that Gilead is investing in new approaches to treat this disease. On behalf of our patients, their families, and the healthcare pressioanls who treat IPF, thank you.

Mark Shreve
Founder
Coalition for Pulmonary Fibrosis (CPF)
http://www.coalitionforpf.org

]]>